Table 2.
Comparison between 2 groups regarding the clinical profile and complications
| Parameter | Units | IISG group n = 46 | IIDSG group n = 29 |
|---|---|---|---|
| Age | years | 51.7 (13.3) | 57.6 (11.5) |
| Sex | M:F | 29 : 17 | 20 : 9 |
| BMI | Kg/m2 | 23.4 (4.5) | 25.6 (4.5) |
| DM duration | Years | 9.9 (4.8) | 10.1 (5) |
| Duration of insulin use | Years | 3.3 (2.9) | 3.6 (2.8) |
| Daily Insulin dose | Units | 28.2 (10.6) | 75.5 (12) |
| Daily Insulin dose | U/Kg | 0.45 (0.15) | 1.1 (0.1) |
| Retinopathy | Number | 21 | 13 |
| Acanthosis | Grade | 0.83 (0.9) | 1.1 (0.8) |
| HbA1c | % | 8.1 (0.59) | 9 (0.78) |
| HDL cholesterol | mg/dL | 40.2 (5.7) | 41 (5) |
| LDL cholesterol | mg/dL | 92.7 (18.5) | 96 (18.9) |
| Triglycerides | mg/dL | 106.7 (37.2) | 107 (44) |
| Serum Iron | μg/dL | 104.5 (22.4) | 112.1 (18.7) |
| Serum Ferritin | ng/mL | 44.7 (18.5) | 53.3 (12.2) |
| Vitamin B12 | pg/mL | 423.3 (102.4) | 397.9 (92.9) |
Mean (S.D).